Frankfurt - Delayed Quote • EUR
Chemed Corporation (CXM.F)
At close: April 26 at 8:01 AM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
2,264,417.00
2,264,417.00
2,134,963.00
2,139,261.00
2,079,583.00
Cost of Revenue
1,465,602.00
1,465,602.00
1,369,877.00
1,369,458.00
1,378,197.00
Gross Profit
798,815.00
798,815.00
765,086.00
769,803.00
701,386.00
Operating Expense
455,985.00
455,985.00
417,899.00
425,778.00
311,706.00
Operating Income
342,830.00
342,830.00
347,187.00
344,025.00
389,680.00
Net Non Operating Interest Income Expense
3,162.00
3,162.00
-4,229.00
-1,491.00
-2,355.00
Other Income Expense
4,375.00
4,375.00
-13,279.00
7,780.00
8,665.00
Pretax Income
350,367.00
350,367.00
329,679.00
350,314.00
395,990.00
Tax Provision
77,858.00
77,858.00
80,055.00
81,764.00
76,524.00
Net Income Common Stockholders
272,509.00
272,509.00
249,624.00
268,550.00
319,466.00
Diluted NI Available to Com Stockholders
272,509.00
272,509.00
249,624.00
268,550.00
319,466.00
Basic EPS
18.11
18.11
16.72
17.14
20.02
Diluted EPS
17.93
17.93
16.53
16.85
19.48
Basic Average Shares
15,050.00
15,050.00
14,929.00
15,671.00
15,955.00
Diluted Average Shares
15,200.00
15,200.00
15,099.00
15,938.00
16,398.00
Total Operating Income as Reported
340,569.00
340,569.00
343,496.00
343,038.00
389,680.00
Total Expenses
1,921,587.00
1,921,587.00
1,787,776.00
1,795,236.00
1,689,903.00
Net Income from Continuing & Discontinued Operation
272,509.00
272,509.00
249,624.00
268,550.00
319,466.00
Normalized Income
274,268.06
274,268.06
252,418.09
269,307.03
319,466.00
Interest Income
6,270.00
6,270.00
355.00
377.00
757.00
Interest Expense
3,108.00
3,108.00
4,584.00
1,868.00
2,355.00
Net Interest Income
3,162.00
3,162.00
-4,229.00
-1,491.00
-2,355.00
EBIT
353,475.00
353,475.00
334,263.00
352,182.00
398,345.00
EBITDA
414,340.00
414,340.00
393,435.00
411,233.00
454,928.00
Reconciled Cost of Revenue
1,465,602.00
1,465,602.00
1,369,877.00
1,369,458.00
1,378,197.00
Reconciled Depreciation
60,865.00
60,865.00
59,172.00
59,051.00
56,583.00
Net Income from Continuing Operation Net Minority Interest
272,509.00
272,509.00
249,624.00
268,550.00
319,466.00
Total Unusual Items Excluding Goodwill
-2,261.00
-2,261.00
-3,691.00
-987.00
-5,130.00
Total Unusual Items
-2,261.00
-2,261.00
-3,691.00
-987.00
-5,130.00
Normalized EBITDA
416,601.00
416,601.00
397,126.00
412,220.00
454,928.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-501.94
-501.94
-896.91
-229.97
--
12/31/2020 - 5/21/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PRF.SG ModivCare Inc
118.00
0.00%
XXY.F Cross Country Healthcare, Inc.
15.90
-1.24%
ZCY.F Cryo-Cell International, Inc.
7.00
+5.26%
PDC.F Pediatrix Medical Group, Inc.
8.15
-4.12%
PRF0.F ModivCare Inc.
22.00
-3.51%
BICX BioCorRx Inc.
0.7500
-8.54%
CCEL Cryo-Cell International, Inc.
8.45
+8.33%
NHC National HealthCare Corporation
91.28
+0.56%
ACHC Acadia Healthcare Company, Inc.
73.59
+0.29%
CLARI.PA Clariane SE
1.8800
+18.69%